LanzaTech Global (NASDAQ:LNZA) Posts Earnings Results, Beats Estimates By $0.01 EPS

LanzaTech Global (NASDAQ:LNZA) posted its quarterly earnings results on Monday. The company reported ($0.10) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.01, Zacks reports. LanzaTech Global had a negative return on equity of 180.10% and a negative net margin of 223.03%.

LanzaTech Global Trading Up 2.0%

Shares of LNZA stock opened at $0.26 on Monday. LanzaTech Global has a 52-week low of $0.14 and a 52-week high of $3.26. The company has a debt-to-equity ratio of 6.64, a quick ratio of 2.91 and a current ratio of 2.91. The firm has a market capitalization of $52.32 million, a PE ratio of -0.41 and a beta of 1.69. The stock has a fifty day simple moving average of $0.27 and a two-hundred day simple moving average of $0.86.

Institutional Inflows and Outflows

An institutional investor recently raised its position in LanzaTech Global stock. AQR Capital Management LLC grew its position in LanzaTech Global, Inc. (NASDAQ:LNZA) by 1,045.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 184,346 shares of the company’s stock after purchasing an additional 168,247 shares during the quarter. AQR Capital Management LLC owned about 0.09% of LanzaTech Global worth $45,000 at the end of the most recent reporting period. 17.76% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, Janney Montgomery Scott lowered LanzaTech Global from a “buy” rating to a “neutral” rating in a report on Thursday, March 13th.

About LanzaTech Global

LanzaTech Global, Inc operates as a nature-based carbon refining company in the United States and internationally. The company transforms waste carbon into the chemical building blocks for consumer goods, such as sustainable fuels, fabrics, and packaging. It is also developing biocatalysts and processes to produce a suite of additional products utilizing novel biocatalysts, including acetone and isopropanol (IPA) and industrial solvents used in various applications, including production of polymers from IPA.